<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="publisher">pcbi</journal-id><journal-id journal-id-type="allenpress-id">plcb</journal-id><journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id><journal-id journal-id-type="pmc">ploscomp</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Computational Biology</journal-title></journal-title-group><issn pub-type="ppub">1553-734X</issn><issn pub-type="epub">1553-7358</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PLCB-RA-0368R3</article-id><article-id pub-id-type="doi">10.1371/journal.pcbi.1000013</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry/Cell Signaling and Trafficking Structures</subject><subject>Biophysics/Cell Signaling and Trafficking Structures</subject><subject>Cell Biology/Cell Growth and Division</subject><subject>Cell Biology/Cell Signaling</subject><subject>Computational Biology/Metabolic Networks</subject><subject>Computational Biology/Signaling Networks</subject><subject>Computational Biology/Synthetic Biology</subject><subject>Computational Biology/Systems Biology</subject><subject>Mathematics</subject><subject>Molecular Biology/Post-Translational Regulation of Gene Expression</subject></subj-group></article-categories><title-group><article-title>Sensing and Integration of Erk and PI3K Signals by Myc</article-title><alt-title alt-title-type="running-head">Integration of Erk and PI3K Signals by Myc</alt-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>Tae</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yao</surname><given-names>Guang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nevins</surname><given-names>Joseph</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>You</surname><given-names>Lingchong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina, United States of America</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America</addr-line>       </aff><contrib-group><contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Tyson</surname><given-names>John J.</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Virginia Polytechnic Institute, United States of America</aff><author-notes><corresp id="cor1">* E-mail: <email xlink:type="simple">you@duke.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: TJL LY. Performed the experiments: TJL. Analyzed the data: TJL GY JRN LY. Wrote the paper: TJL. Critical reading of the manuscript: GY JRN.</p></fn><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><month>2</month><year>2008</year></pub-date><pub-date pub-type="epub"><day>29</day><month>2</month><year>2008</year></pub-date><volume>4</volume><issue>2</issue><elocation-id>e1000013</elocation-id><history><date date-type="received"><day>29</day><month>6</month><year>2007</year></date><date date-type="accepted"><day>29</day><month>1</month><year>2008</year></date></history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2008</copyright-year><copyright-holder>Lee et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><p>The transcription factor Myc plays a central role in regulating cell-fate decisions, including proliferation, growth, and apoptosis. To maintain a normal cell physiology, it is critical that the control of Myc dynamics is precisely orchestrated. Recent studies suggest that such control of Myc can be achieved at the post-translational level via protein stability modulation. Myc is regulated by two Ras effector pathways: the extracellular signal-regulated kinase (Erk) and phosphatidylinositol 3-kinase (PI3K) pathways. To gain quantitative insight into Myc dynamics, we have developed a mathematical model to analyze post-translational regulation of Myc via sequential phosphorylation by Erk and PI3K. Our results suggest that Myc integrates Erk and PI3K signals to result in various cellular responses by differential stability control of Myc protein isoforms. Such signal integration confers a flexible dynamic range for the system output, governed by stability change. In addition, signal integration may require saturation of the input signals, leading to sensitive signal integration to the temporal features of the input signals, insensitive response to their amplitudes, and resistance to input fluctuations. We further propose that these characteristics of the protein stability control module in Myc may be commonly utilized in various cell types and classes of proteins.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>The transcription factor Myc plays a critical role in regulating diverse cell-fate decisions, including growth, proliferation, and programmed cell death. Underscoring its importance, Myc expression is often found to be deregulated in cancers. However, the dynamic mechanism by which Myc is controlled by its upstream signaling proteins remains unclear. To address this issue, we analyze a well-defined signaling module for Myc regulation using a kinetic model constrained by experimental data and observations. In this module, Myc acts as an integrator of its upstream signals that differentially regulate its stability. We show that this module can enable highly sensitive Myc response to the temporal features of the input signals, but not to their maximum amplitudes. We further suggest that this module represents a generic post-translational mechanism for signal sensing and integration in diverse signaling networks. Our work offers insight into the “design” of natural biological networks and makes predictions that can guide further experimental studies on Myc regulation. Moreover, it defines a simple signal processing unit that may be useful for engineering synthetic gene circuits to carry out cell-based computation.</p></abstract><funding-group><funding-statement>This work was supported by grants from the NIH 5-U24-CA112952-03 (to JRN), NSF BES-0625213 (to LY), and David and Lucile Packard Fellowship (to LY).</funding-statement></funding-group><counts><page-count count="9"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>The proto-oncogene protein Myc is a transcription factor that regulates numerous signaling pathways involved in cell-fate decisions <xref ref-type="bibr" rid="pcbi.1000013-Pelengaris1">[1]</xref>–<xref ref-type="bibr" rid="pcbi.1000013-Secombe1">[4]</xref>. Sufficient accumulation of Myc leads to the activation of Cyclin D and cyclin dependent kinases, which subsequently phosphorylate Rb and release E2F. This results in the initiation of DNA replication and cell cycle entry <xref ref-type="bibr" rid="pcbi.1000013-Bouchard1">[5]</xref>. Excessive accumulation of Myc, however, induces apoptosis <xref ref-type="bibr" rid="pcbi.1000013-Evan1">[6]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Prendergast1">[7]</xref> when cells are under stress or deprived of growth factors. Finally, Myc also drives cell growth by activating genes that encode cellular metabolic activities, including translational factors, ribosomal proteins and RNAs <xref ref-type="bibr" rid="pcbi.1000013-Schmidt1">[8]</xref>.</p><p>Given its importance, Myc activity must be properly controlled in response to different environmental cues. Past studies have suggested that Myc is regulated at multiple levels, including auto-regulation of Myc transcription <xref ref-type="bibr" rid="pcbi.1000013-Penn1">[9]</xref> and post-transcriptional regulation <xref ref-type="bibr" rid="pcbi.1000013-Endo1">[10]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Levine1">[11]</xref>. More recent discoveries indicate that Myc is also dynamically regulated at the protein level by the Ras effector pathways <xref ref-type="bibr" rid="pcbi.1000013-Sears1">[12]</xref>–<xref ref-type="bibr" rid="pcbi.1000013-EscamillaPowers1">[15]</xref>. These discoveries suggest that Myc protein undergoes a series of modifications that are sequential and irreversible <xref ref-type="bibr" rid="pcbi.1000013-Sears1">[12]</xref>–<xref ref-type="bibr" rid="pcbi.1000013-Yeh1">[14]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Kumar1">[16]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Sears3">[17]</xref>. More specifically, when Myc is newly synthesized, it is highly unstable and quickly undergoes ubiquitination and degradation <xref ref-type="bibr" rid="pcbi.1000013-Gregory1">[18]</xref>. It can be substantially stabilized when phosphorylated at serine 62 (Ser62) by Ras-activated Erk activity (<xref ref-type="fig" rid="pcbi-1000013-g001">Figure 1A</xref>). Subsequent phosphorylation of Myc at threonine 58 (Thr58) by Gsk3β, however, initiates a destabilization process in a sequential manner. This is achieved by a dephosphorylation mechanism by a prolyl isomerase Pin1 and a protein phosphatase PP2A. Once Myc is phosphorylated at Thr58 (Myc<sup>Ser62-Thr58</sup>), Pin1 induces it to undergo conformation changes, which are required for PP2A to dephosphorylate the Ser62 residue (Myc<sup>Thr58</sup>) <xref ref-type="bibr" rid="pcbi.1000013-Yeh1">[14]</xref>. To date, this is the only dephosphorylation mechanism identified in the Myc stabilization processes. Destabilization of Myc by Gsk3β can be blocked by the Ras-activated PI3K pathway (<xref ref-type="fig" rid="pcbi-1000013-g001">Figure 1A</xref>).</p><fig id="pcbi-1000013-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000013.g001</object-id><label>Figure 1</label><caption><title>Myc protein stabilization for Myc accumulation.</title><p>(A) Stimulation with growth factors (GF) leads to activation of Ras and Myc synthesis. Active Ras induces activation of its downstream effector pathways: the MAPK and PI3K pathways. While the synthesized Myc is unstable with short half-life, its stability can be significantly increased via the Ras effector pathways. Active Ras induces Erk that stabilizes Myc by phosphorylation at Ser62. PI3K activation blocks Myc degradation by inhibiting phosphorylation at Thr58 by Gsk3β. As Ras activity declines, Gsk3β initiates phosphorylation of Myc at Thr58 and triggers degradation. Phosphorylation at Thr58 requires prior phosphorylation at Ser62, and phosphorylation at Thr58 induces dephosphorylation at Ser62. (B) Activation patterns of Erk and PI3K determine Myc stability pattern. The three forms of Myc are plotted independently. The unmodified Myc (blue line) and Myc<sup>Thr58</sup> (green line) accumulate only to a limited level, but stabilized Myc<sup>Ser62</sup> level increases via phosphorylation (red line). The total Myc level is the sum of the three forms of Myc (black line) and its dynamics are highly correlated with input signals, Erk, and PI3K. We define the shaded area under the Myc curve as “potency”, a measure of Myc accumulation.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.g001" xlink:type="simple"/></fig><p>The unique control of Myc dynamics by sequential phosphorylation allows Myc to integrate upstream signals from Erk and PI3K, which play critical roles in controlling diverse cell fates <xref ref-type="bibr" rid="pcbi.1000013-Yeh1">[14]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Vojtek1">[19]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Ebisuya1">[20]</xref>. Erk often exhibits an early, transient peak of activation upon growth stimulation (<xref ref-type="supplementary-material" rid="pcbi.1000013.s006">Table S1</xref>). The peak is followed by varying residual activities, which depend on cell lines and growth factors. This residual Erk is critical in downstream signal encoding. For example, in PC12 cells, a small residual Erk activity, as a result of epidermal growth factor (EGF) stimulation, leads to proliferation. In contrast, a high residual Erk activity as a result of nerve growth factor (NGF) stimulation in the same cell line leads to differentiation <xref ref-type="bibr" rid="pcbi.1000013-Sasagawa1">[21]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Traverse1">[22]</xref>. The residual Erk level has also been observed to be critical in regulating c-Fos level in fibroblasts <xref ref-type="bibr" rid="pcbi.1000013-Murphy1">[23]</xref>.</p><p>The PI3K activation pattern depends on cell lines and stimulants, as detailed in <xref ref-type="supplementary-material" rid="pcbi.1000013.s007">Table S2</xref>. It is bimodal (having two peaks) in various cell lines including WI38, NIH 3T3, or HepG2 when stimulated by platelet-derived growth factors (PDGF) or fetal bovine serum (FBS) <xref ref-type="bibr" rid="pcbi.1000013-Kumar1">[16]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Chaussepied1">[24]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Jones1">[25]</xref>. In contrast, PI3K appears to have only an early, transient single peak in the U-2OS or PVSM cell lines stimulated with other growth stimulants <xref ref-type="bibr" rid="pcbi.1000013-Chaussepied1">[24]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Goncharova1">[26]</xref>. The bimodal activation of PI3K has been shown to be important for cell cycle regulation <xref ref-type="bibr" rid="pcbi.1000013-Jones1">[25]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Jones2">[27]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Garcia1">[28]</xref>. In particular, the second peak has been found sufficient and critical to drive the G1/S transition during cell cycle <xref ref-type="bibr" rid="pcbi.1000013-Kumar1">[16]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Jones2">[27]</xref>.</p><p>The temporal pattern of Myc activation closely correlates with those of Erk and PI3K (<xref ref-type="supplementary-material" rid="pcbi.1000013.s008">Table S3</xref>). Myc protein reaches its peak at ∼2 hours after growth stimulation and decreases to and remains at an intermediate value, or hump, for over ∼6 hours before reducing to its basal level <xref ref-type="bibr" rid="pcbi.1000013-Kumar1">[16]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-ODonnell1">[29]</xref>. The peak and the hump of Myc coincide with the Erk peak (also the 1<sup>st</sup> PI3K pulse) and the 2<sup>nd</sup> PI3K pulse, respectively. These observations suggest that Myc may sense and integrate signals from its two regulators (Erk and PI3K).</p><p>To gain insight into this control mechanism, we have constructed a mathematical model to analyze dynamics of Myc accumulation controlled by sequential phosphorylation. Using this model, we aimed to investigate how signaling patterns of Erk and PI3K regulate Myc dynamics at the post-translational level. Also, how robust is Myc dynamics with respect to network parameters, such as phosphorylation and dephosphorylation rate constants? What is unique about this strategy of controlling Myc accumulation by sequentially modulating protein stability? Is this a common strategy by which cells achieve reliable temporal control of key regulatory proteins? By exploring these questions, our work may provide insights into design features of cell signaling networks and guidance for experimental intervention. Conceptually, our model defines a unique module that connects with other models that deal with upstream signaling dynamics leading to the activation of Erk <xref ref-type="bibr" rid="pcbi.1000013-Sasagawa1">[21]</xref> or PI3K <xref ref-type="bibr" rid="pcbi.1000013-Park1">[30]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Kaur1">[31]</xref>, as well as downstream dynamics leading to mammalian cell fate decisions <xref ref-type="bibr" rid="pcbi.1000013-Novak1">[32]</xref>–<xref ref-type="bibr" rid="pcbi.1000013-Qu1">[34]</xref> We further propose that post-translation regulation of Myc represents an example of a generic dual-kinase motif. With appropriate parameters, this motif will enable precise temporal sensing of input signals.</p></sec><sec id="s2"><title>Results/Discussion</title><sec id="s2a"><title>The Base Simulation</title><p>The Myc temporal dynamics, simulated with reaction kinetics and base parameter values in <xref ref-type="supplementary-material" rid="pcbi.1000013.s009">Table S4</xref> and <xref ref-type="supplementary-material" rid="pcbi.1000013.s010">S5</xref>, was overall consistent with experimental observations in <xref ref-type="fig" rid="pcbi-1000013-g001">Figure 1B</xref> <xref ref-type="bibr" rid="pcbi.1000013-Jones2">[27]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-ODonnell1">[29]</xref>. To achieve this consistency, however, we found that the input signals Erk and PI3K needed to operate at or close to saturation, and there needed to be sufficient residual Erk (Erk<sub>R</sub>) before the second PI3K pulse (See the next section, as well as <xref ref-type="supplementary-material" rid="pcbi.1000013.s009">Tables S4</xref> and <xref ref-type="supplementary-material" rid="pcbi.1000013.s010">S5</xref>). In the base simulation (<xref ref-type="fig" rid="pcbi-1000013-g001">Figure 1B</xref>), the total Myc (black line) consisted of unmodified, unstable Myc (blue line), stable Myc<sup>Ser62</sup> (red line), and unstable Myc<sup>Thr58 </sup>(green line). Although phosphorylation state affects transactivation capacity <xref ref-type="bibr" rid="pcbi.1000013-Yeh1">[14]</xref>, the contribution from Myc<sup>Ser62</sup> to total Myc was much more significant than that from Myc<sup>Thr58</sup>. Therefore, we assumed that the overall transactivation capacity of Myc does not change significantly during Myc modulation. The modification of Myc from its unstable to stable form, then back to unstable form closely followed Erk and PI3K signals. The first peak of Myc coincided with the Erk pulse and the first PI3K pulse. After these initial pulses, unmodified Myc and Myc<sup>Ser62</sup> recovered to new steady state levels, which depended on the rate constants of Myc synthesis, phosphorylation, and degradation. Before Myc<sup>Ser62</sup> reached its new steady state, however, PI3K pulse became activated for the second time and prevented Myc<sup>Ser62</sup> from converting to the unstable form, sustaining total amount of Myc at high level. Once the second PI3K pulse subsided, Myc<sup>Ser62</sup> was turned to Myc<sup>Thr58</sup> via phosphorylation by Gsk3β. In other words, while Erk and the first peak of PI3K determine initial Myc accumulation, the second peak of PI3K prevents Myc from receding to a lower level, thus fine-tuning the Myc level.</p><p>As Myc accumulation was determined by conversion between its unstable forms and stable form, we expected Myc accumulation to depend on the degradation rate constant of each form. As a quantitative estimate for Myc accumulation, we used Myc potency, the shaded area in <xref ref-type="fig" rid="pcbi-1000013-g001">Figure 1B</xref>. If Myc became stabilized quickly and remained stabilized for an extended period of time, Myc potency would be high. In contrast, slow stabilization and quick destabilization would yield small potency. Consistent with these notions, our sensitivity analysis indicated that Myc potency was highly sensitive to parameters involved in stabilization of Myc and maintenance of the stable form (<xref ref-type="supplementary-material" rid="pcbi.1000013.s011">Table S6</xref>). In comparison, other parameters governing the signal transduction in the PI3K pathway had little impact on Myc potency (<xref ref-type="supplementary-material" rid="pcbi.1000013.s012">Table S7</xref>). This may partially result from the signaling transduction in the PI3K pathway operating with zero-order ultrasensitivity around the base parameter setting (see <xref ref-type="supplementary-material" rid="pcbi.1000013.s002">Figures S2</xref> and <xref ref-type="supplementary-material" rid="pcbi.1000013.s005">S5</xref> for additional analysis and discussion), which may explain robustness to random perturbation in a signaling cascade <xref ref-type="bibr" rid="pcbi.1000013-Wang1">[35]</xref>.</p></sec><sec id="s2b"><title>Effects of Erk and PI3K Signal Patterns on Myc Accumulation</title><p>Erk and PI3K activation patterns, which determine the temporal dynamics of Myc, may vary significantly under different growth conditions and in different cell lines (<xref ref-type="supplementary-material" rid="pcbi.1000013.s006">Table S1</xref> and <xref ref-type="supplementary-material" rid="pcbi.1000013.s007">S2</xref>). Here we investigated how Myc potency responds to varying patterns of Erk and PI3K signals. Whenever possible, model predictions were compared with existing experimental observations. When the latter are unavailable, our model predictions may serve as testable hypothesis for future experiments, which in turn can further constrain our model. As shown in <xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2</xref>, we quantitatively represented input signals of Erk and PI3K with the following parameters: duration (Dur<sub>E</sub> and Dur<sub>P</sub>), maximal amplitude (Erk<sub>Max</sub> and PI3K<sub>Max</sub>), and residual level (Erk<sub>R</sub> and PI3K<sub>R</sub>). For PI3K, we used an additional parameter to describe the time interval between the two peaks (IP<sub>P</sub>).</p><fig id="pcbi-1000013-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000013.g002</object-id><label>Figure 2</label><caption><title>Erk and PI3K signal patterns determine Myc temporal behaviors.</title><p>For all analyses, black lines represent the base case. (A) The Erk signal was represented with the following parameters: duration (Dur<sub>E</sub>), maximal Erk amplitude (Erk<sub>Max</sub>), and residual Erk level (Erk<sub>R</sub>). (B) The PI3K signal was represented with the following parameters: duration (Dur<sub>P</sub>), maximal PI3K amplitude (PI3K<sub>Max</sub>), residual PI3K level (PI3K<sub>R</sub>), and the time interval between the two peaks of PI3K (IP<sub>P</sub>). The first peak of the PI3K was not considered, since its variations did not have a big impact. (C) Myc accumulation was insensitive to Erk<sub>Max</sub>. Fivefold increase in Erk<sub>Max</sub> resulted in little change in Myc (red line) in comparison to the base case (black line), whereas fivefold decrease in Erk<sub>Max</sub> resulted in light reduction in the main peak of Myc (blue line). (D) Doubling (red line) or halving (blue line) Dur<sub>E</sub> leads to significant change in the initial peak of Myc accumulation. (E) Myc was sensitive to Erk<sub>R</sub>. The base value of Erk<sub>R</sub> was 10 percent of Erk<sub>Max</sub> (black line). A small increase in Erk<sub>R</sub> (20% of Erk<sub>Max</sub>) resulted in excessive Myc accumulation (red line). When Erk was completely removed (Erk<sub>R</sub> = 0), Myc responded only to the initial, transient Erk pulse and became unresponsive to the PI3K signal (blue line). (F) Myc accumulation was insensitive to PI3K<sub>Max</sub>. Fivefold increase (red line) or decrease (blue line) in PI3K<sub>Max</sub> resulted in little change in Myc accumulation. (G) The 2<sup>nd</sup> PI3K peak determined generation and maintenance of Myc hump. Doubling (red line) or halving (blue line) the duration of the second PI3K peak led to approximately twofold change in the Myc hump duration. Increasing IP<sub>P</sub> from 3 hours to 8 hours delayed the timing of the second rise in Myc accumulation (red dotted line). (H) A slight increase (20% of PI3K<sub>Max</sub>) in PI3K<sub>R</sub> from the base value (10% of PI3K<sub>Max</sub>) resulted in excessive Myc accumulation (red line). However, complete removal of PI3K<sub>R</sub> did not change Myc accumulation significantly (blue line overlapping with black line).</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.g002" xlink:type="simple"/></fig><p>Our analysis predicted Myc accumulation to be insensitive to further increase in Erk amplitude. A fivefold increase in Erk<sub>Max</sub> caused little change in Myc accumulation (<xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2C</xref>). A fivefold decrease in Erk<sub>Max</sub>, however, predicted a slight but discernable decrease in Myc accumulation. These results indicated that the base case of Erk was operating at saturation. As a result, this behavior enabled the system to be insensitive to minor changes in Erk amplitude, unless the Erk amplitude became sufficiently small. In comparison, the Myc potency was much more sensitive to the duration of Erk pulse: excessive accumulation of Myc was also observed when the duration of Erk was doubled (red line in <xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2D</xref>). Halving Erk duration resulted in significant reduction in the initial peak of Myc.</p><p>Myc potency was sensitive to the residual Erk level (Erk<sub>R</sub>). Without it (Erk<sub>R</sub> = 0), the total Myc level quickly reduced to a low level following the Erk pulse (blue line in <xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2E</xref>). Conversely, a mere twofold increase in Erk<sub>R</sub> from the base value ( = 10% of Erk<sub>Max</sub>) led to excessive Myc accumulation (red line in <xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2E</xref>). These results highlighted the importance of Erk<sub>R</sub> in fine-tuning total Myc accumulation. In particular, Erk<sub>R</sub> was important for maintaining sufficient Myc level before the arrival of the second PI3K pulse, by providing a moderate rate of Myc stabilization. In a more extreme case where the Erk signal was completely removed, no Myc accumulation was observed (data not shown). These results may provide a mechanistic explanation for differential phenotypic responses to varying residual level of Erk <xref ref-type="bibr" rid="pcbi.1000013-Sasagawa1">[21]</xref>. In PC12 cells proliferation was correlated with low residual level of Erk, while high residual level of Erk was observed for differentiation. Based on our simulations, we suggest that differential regulation of Myc accumulation may be involved in determining these diverging phenotypic behaviors of these cells. This prediction can be tested by further experiments.</p><p>Similarly, Myc accumulation was insensitive to the maximum amplitude of PI3K (PI3K<sub>Max</sub>), but much more sensitive to its residual level (PI3K<sub>R</sub>) and temporal features, including duration of the 2<sup>nd</sup> peak (Dur<sub>P</sub>) and time interval between the two peaks (IP<sub>P</sub>). Five-fold increase or decrease in PI3K<sub>Max</sub> resulted in little change in Myc accumulation (<xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2F</xref>). However, doubling or halving the duration of the 2<sup>nd</sup> PI3K peak caused an approximately two fold change in the duration of the Myc hump (<xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2G</xref>). Complete removal of the 2<sup>nd</sup> PI3K peak eliminated the Myc hump (<xref ref-type="supplementary-material" rid="pcbi.1000013.s003">Figure S3A</xref>). This indicates that the 2<sup>nd</sup> PI3K peak was primarily responsible for generating and maintaining the hump in Myc activation. These results are consistent with recent experimental data: removal of the 2<sup>nd</sup> PI3K peak by using a PI3K inhibitor <xref ref-type="bibr" rid="pcbi.1000013-Kumar1">[16]</xref> or by acid washing <xref ref-type="bibr" rid="pcbi.1000013-Jones2">[27]</xref> drastically reduced total Myc accumulation. Given this role of the 2<sup>nd</sup> PI3K peak, the time interval between the two peaks of PI3K was critical for determining Myc accumulation pattern (dotted red line in <xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2G</xref>). This is highlighted by a variable time interval across different cell lines or growth conditions. For example, the PI3K inter-peak delay is 3∼4 hours in HepG2 cells <xref ref-type="bibr" rid="pcbi.1000013-Jones1">[25]</xref> but approximately 8 hours in NIH 3T3 cells <xref ref-type="bibr" rid="pcbi.1000013-Kumar1">[16]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Jones1">[25]</xref>. Our model was able to account for Myc accumulation pattern in both conditions by varying only the time-interval (either 3 hrs or 8 hours) between the two peaks of PI3K (<xref ref-type="supplementary-material" rid="pcbi.1000013.s003">Figure S3B</xref>).</p><p>Another sensitive parameter of PI3K was its residual level. A mere two-fold increase in the residual level from the base case (10% of PI3K<sub>Max</sub>), resulted in excessive increase in Myc level (red line in <xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2H</xref>), consistent with an experimental study where exogenous Akt expression induced significantly increased Myc protein levels <xref ref-type="bibr" rid="pcbi.1000013-Segrelles1">[36]</xref>. Interestingly, however, PI3K<sub>R </sub>below a certain threshold level did not have much impact on Myc accumulation (blue line overlapping with black line in <xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2H</xref>). Such threshold effect is due to the ultrasensitivity in the PI3K signaling cascade (<xref ref-type="supplementary-material" rid="pcbi.1000013.s002">Figures S2</xref> and <xref ref-type="fig" rid="pcbi-1000013-g005">5</xref>). If the change in the PI3K residual level triggers a digital switching behavior, it can cause a large change in the output (black to red lines in <xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2H</xref>). Any change in the residual level outside the ultrasensitive region will not cause any significant output change.</p><p>The results in <xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2</xref> suggest that Myc accumulation was insensitive to changes in the maximum amplitude of Erk and PI3K signals (<xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2C and 2F</xref>), but much more sensitive to their temporal features such as duration and inter-peak time delay, and their residual values (<xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2D, 2E, 2G, and 2H</xref>). This occurred because the maximum amplitudes of Erk and PI3K pulses were at their saturation level. That is, when the Erk pulse is sufficiently strong, Myc is almost completely converted into Myc<sup>Ser62</sup>; strong PI3K pulses block further phosphorylation of Myc<sup>Ser62</sup> to Myc<sup>Thr58</sup>. If so, this mechanism will allow cells to resist further changes in Erk and PI3K amplitudes. Such resistance (or insensitivity) to amplitude changes (or fluctuations) of Erk and PI3K may underlie precise control of signal transduction by Myc, given its role as a key regulator of downstream cellular events. That is, dysregulation of Myc activities, which is a signature of various cancers, may have detrimental consequences <xref ref-type="bibr" rid="pcbi.1000013-Nilsson1">[37]</xref>. To prevent such dysregulation, activation or deactivation cues must be transmitted and integrated precisely to regulate Myc accumulation. We note that this noise-resistance, which we define as insensitivity to the changes in Erk or PI3K level in individual cells, requires the maximum amplitudes of Erk and PI3K to be sufficiently large. If their amplitudes and residual values are set 10 fold lower, the Myc accumulation becomes much more sensitive to perturbations around the new base values.</p></sec><sec id="s2c"><title>The Dual-Kinase Motif as a Generic Signal Integrator</title><p>The Erk and PI3K pathways that control Myc protein turnover are conserved in yeast <xref ref-type="bibr" rid="pcbi.1000013-EscamillaPowers1">[15]</xref>, and may represent a general post-translational strategy in natural signaling pathways <xref ref-type="bibr" rid="pcbi.1000013-Assoian1">[38]</xref>–<xref ref-type="bibr" rid="pcbi.1000013-Liu1">[44]</xref> (<xref ref-type="table" rid="pcbi-1000013-t001">Table 1</xref>). For instance, β-catenin stability is regulated by casein kinase Iα (CKIα) and Gsk3β <xref ref-type="bibr" rid="pcbi.1000013-Amit1">[42]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Liu1">[44]</xref>. Similarly, an unknown kinase and Gsk3β coordinate to modulate microtubule (MT) stabilizing activity <xref ref-type="bibr" rid="pcbi.1000013-Hergovich1">[43]</xref>. These examples consist of a dual-kinase motif that integrates two independent input signals (<xref ref-type="fig" rid="pcbi-1000013-g003">Figure 3A</xref>). In this motif, X represents the unphosphorylated effector protein, which is unstable. It can be stabilized by kinase S<sub>1</sub> through phosphorylation (becoming Xp) and subsequently destabilized by kinase S<sub>2</sub> through additional phosphorylation (becoming Xpp), as shown in <xref ref-type="fig" rid="pcbi-1000013-g003">Figure 3B</xref>.</p><fig id="pcbi-1000013-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000013.g003</object-id><label>Figure 3</label><caption><title>Dual-kinase module as a signal integrator.</title><p>(A) The dual-kinase mechanism. <italic>S<sub>1</sub></italic> and <italic>S<sub>2</sub></italic> determine gain and loss of X stability by sequential phosphorylation, which in turn control the total amount of the target protein (<italic>x<sub>T</sub></italic> = <italic>x</italic>+<italic>x<sub>P</sub></italic>+<italic>x<sub>PP</sub></italic>). <italic>k<sub>1</sub></italic> and <italic>k<sub>2</sub></italic> are the rate constants for phosphorylation by S1 and S2, respectively. <italic>d<sub>X</sub></italic> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000013.e001" xlink:type="simple"/></inline-formula> are degradation rate constants of the unstable (<italic>X</italic> or <italic>X<sub>pp</sub></italic>) and stable (<italic>X<sub>p</sub></italic>) forms of X. (B) Given sufficiently strong input signals S<sub>1</sub> and S<sub>2</sub>, the dual kinase mechanism integrates upstream activating signal S<sub>1</sub> to turn on, and deactivating signal S<sub>2</sub> to turn off. The time delay between the two signals controls the duration of activation.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.g003" xlink:type="simple"/></fig><table-wrap id="pcbi-1000013-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000013.t001</object-id><label>Table 1</label><caption><title>Examples of protein modulation by sequential phosphorylation</title></caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pcbi-1000013-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.t001" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Enzymes</td><td align="left" colspan="1" rowspan="1">Module function</td><td align="left" colspan="1" rowspan="1">References</td></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Myc</td><td align="left" colspan="1" rowspan="1">Erk, PI3K</td><td align="left" colspan="1" rowspan="1">Protein stabilization</td><td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pcbi.1000013-Sears1">[12]</xref>–<xref ref-type="bibr" rid="pcbi.1000013-Yeh1">[14]</xref></td></tr><tr><td align="left" colspan="1" rowspan="1">Fos</td><td align="left" colspan="1" rowspan="1">Erk</td><td align="left" colspan="1" rowspan="1">Protein stabilization</td><td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pcbi.1000013-Assoian1">[38]</xref></td></tr><tr><td align="left" colspan="1" rowspan="1">Jun</td><td align="left" colspan="1" rowspan="1">JNK, Erk</td><td align="left" colspan="1" rowspan="1">Protein stabilization</td><td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pcbi.1000013-Musti1">[39]</xref></td></tr><tr><td align="left" colspan="1" rowspan="1">Β-catenin</td><td align="left" colspan="1" rowspan="1">CKIα, Gsk3β</td><td align="left" colspan="1" rowspan="1">Protein stabilization</td><td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pcbi.1000013-Amit1">[42]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Liu1">[44]</xref></td></tr><tr><td align="left" colspan="1" rowspan="1">LPR6</td><td align="left" colspan="1" rowspan="1">Gsk3 β, CK1</td><td align="left" colspan="1" rowspan="1">Axin binding</td><td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pcbi.1000013-Zeng1">[40]</xref></td></tr><tr><td align="left" colspan="1" rowspan="1">CDC25A</td><td align="left" colspan="1" rowspan="1">B-Cdk1, ATM-Chk2</td><td align="left" colspan="1" rowspan="1">Stabilization</td><td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pcbi.1000013-Mailand1">[41]</xref></td></tr></tbody></table></alternatives></table-wrap><p>The wide presence of this motif suggests its potential advantages for cellular signal processing. To gain insights into this issue, we developed a simplified model to analyze dynamics of the dual-kinase motif (see <xref ref-type="sec" rid="s3">Model and Methods</xref>). In the model, we treated the two inputs of the system (<xref ref-type="fig" rid="pcbi-1000013-g003">Figure 3A</xref>) as independent, decoupled upstream signals, since most of the dual-kinase motifs found in nature often integrate independent upstream signals. Using this model, we aimed to explore what properties of this basic motif may underlie the dynamics observed for Myc regulation, and what advantages these properties may confer in cellular signaling.</p><p>To characterize the dual-kinase motif, we first examined dose response of the system with respect to the two inputs S<sub>1</sub> and S<sub>2</sub>. Our results indicated that system activation (through phosphorylation by S<sub>1</sub>) was sensitive to input variations at an intermediate <italic>α</italic> value (<xref ref-type="fig" rid="pcbi-1000013-g004">Figure 4A</xref>). In contrast, it was insensitive to input variations at either high or low <italic>α</italic> values (green curve). Similar insensitivity (or noise-resistance) at either strong or weak input signals was observed for system deactivation (<xref ref-type="fig" rid="pcbi-1000013-g004">Figure 4B</xref>) for varying β. These results provide a mechanistic explanation for the insensitivity of Myc potency to input signal strengths (<xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2C and 2F</xref>).</p><fig id="pcbi-1000013-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000013.g004</object-id><label>Figure 4</label><caption><title>System sensitivity to input signal perturbations.</title><p>(A) At a given synthesis rate constant (<italic>κ</italic> = 10), the maximal activated level of X at the steady-state (X<sub>ss</sub>) can be modulated by <italic>α</italic>. For small or large <italic>α</italic>, sensitivity (defined as ln <italic>X</italic>/ln <italic>α</italic>) was minimal, while it was the greatest at intermediate <italic>α</italic> values. We assumed 0 for <italic>β</italic> to allow decoupling of activation from deactivation. (B) Deactivation from the high state depended on <italic>β</italic> at a given <italic>κ</italic>. The system was initially driven to its high state by assuming a large <italic>α</italic> (10,000). Sensitivity was minimal for small or large <italic>β</italic>, and was the greatest at intermediate <italic>β</italic> values.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.g004" xlink:type="simple"/></fig><p>Another salient feature of the dual kinase motif was the stabilization of X, which could be captured by the stabilization efficiency (<italic>η</italic>), or the ratio between the degradation rate constant of the unstable form and that of the stable form. Our analysis indicated that the stabilization efficiency determines the dynamic range of the output X. In response to S<sub>1</sub>, the upper bound of output was set by the synthesis rate of X (<italic>κ</italic>) and was asymptotically approached as the signal strength (α) increasedh (<xref ref-type="fig" rid="pcbi-1000013-g005">Figure 5A</xref>). The lower bound of the output, however, was set by <italic>κ/η</italic>, which corresponded to the basal level of X in the absence of S<sub>1</sub>. Thus, <italic>η</italic> directly set the dynamic range of the output (<italic>κ/η</italic>∼<italic>κ</italic>). Similar dependence was also applied to deactivation of X by S<sub>2</sub> (<xref ref-type="fig" rid="pcbi-1000013-g005">Figure 5B</xref>). Given saturating activation by S<sub>1</sub>, the dynamic range for deactivation by S<sub>2</sub> increased with increasing <italic>η,</italic> allowing the dynamic range to be flexible. The system approached the basal output level (<italic>κ/η</italic>) with an increasing strength of S<sub>2</sub> (β→∞).</p><fig id="pcbi-1000013-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000013.g005</object-id><label>Figure 5</label><caption><title>Dynamic range of output activation and deactivation.</title><p>(A) The dynamic range for activation was <italic>η</italic> because: X<sub>ss</sub>≈<italic>κ/η</italic> as <italic>α</italic>→0; X<sub>ss</sub>≈<italic>κ</italic> as <italic>α</italic>→∞. For a given <italic>η</italic>, we define a critical value <italic>α<sub>C</sub></italic> that corresponds to an X<sub>SS</sub> = 95% of the maximal value. If <italic>α</italic>&gt;<italic>α<sub>C</sub></italic>, fluctuations in X<sub>ss</sub> due to fluctuations in <italic>α</italic> would be smaller than 5%. Here we consider system activation in this parameter range as effectively noise-resistant. Similar to analyses in <xref ref-type="fig" rid="pcbi-1000013-g004">Figure 4</xref>, we assumed 0 for <italic>β</italic> and a large value (10,000) for <italic>α</italic>, which allowed analyzing dynamic range for activation and deactivation independently. (B) Given a sufficiently large <italic>α</italic>, the dynamic range for system deactivation was also <italic>η</italic> because: X<sub>ss</sub>≈<italic>κ</italic> as <italic>β</italic>→0; X<sub>ss</sub>≈<italic>κ/η</italic> as <italic>β</italic>→∞. For a given <italic>η</italic>, we define a critical value <italic>β<sub>C</sub></italic> that corresponds to X<sub>ss</sub> within 5% of its minimal value. Similar to (A), we consider system deactivation to be effectively noise-resistant for <italic>β&gt;β<sub>C</sub></italic>. (C) <italic>α<sub>C</sub></italic> increased with <italic>η</italic> almost linearly. (D) <italic>β<sub>C</sub></italic> increased with <italic>η</italic> almost linearly.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.g005" xlink:type="simple"/></fig><p>These results highlight two appealing features of the dual kinase motif. First, differential stability control on effector protein isoforms enables flexible modulation of the output dynamic range. This dynamic range can be fully exploited if the signal strengths are sufficiently large. Second, sufficiently strong signals will also result in desensitization of the system output to minor fluctuations in the levels of these signals.</p><p>While advantageous, however, increase in noise-resistance and dynamic range comes with increasing metabolic cost. On one hand, increasing destabilization of X or Xpp is associated with increasing metabolic cost. On the other, this will also require stronger input signals to fully exploit the increased dynamic range and to achieve noise-resistance, creating another metabolic burden as characterized by <italic>α</italic> and <italic>β</italic>. To quantify this effect, we define a critical <italic>α</italic> value (<italic>α<sub>C</sub></italic>), which corresponds to a steady-state X (Xss) value at 95% of the maximum X (for <italic>α</italic>→<italic>∞)</italic>. If the input signal would fluctuate in the range of <italic>α</italic>&gt;<italic>α<sub>C</sub></italic>, the resulting output fluctuation would never exceed 5% (regardless of the magnitude of input signal fluctuation). Here we can consider system activation as noise-resistant in this parameter range. With similar reasoning, we define a critical <italic>β<sub>C</sub></italic>, which corresponds to an Xss value within 5% of the minimum X (for <italic>β</italic>→<italic>∞</italic>). <italic>α<sub>C</sub></italic> and <italic>β<sub>C</sub></italic> thus determine the minimal signal strengths required to achieve noise-resistance in system activation or deactivation. As shown <xref ref-type="fig" rid="pcbi-1000013-g005">Figure 5C and 5D</xref>, the greater the stabilization efficiency was (larger <italic>η</italic>), the heavier would be the corresponding metabolic burden (larger <italic>α<sub>C</sub></italic> or <italic>β<sub>C</sub></italic>) required to achieve noise-resistance. Insufficient input signal strength would either fail to generate response or fall into the sensitive range of the dose response curve (<xref ref-type="fig" rid="pcbi-1000013-g004">Figure 4</xref>).</p><p>Here we demonstrate that modulation of Myc stability by sequential phosphorylation enables Myc to precisely sense and integrate upstream Erk and PI3K signals. Such regulation is likely critical to cell fate decisions. Our analysis indicates that, when operating with appropriate parameters, this mechanism enables the temporal features, instead of maximum amplitudes, of the upstream signals to precisely modulate Myc accumulation. Supporting this notion, dynamics of a minimal dual-kinase motif provide direct, intuitive explanation for the key sensitivity properties of Myc output in the full model. In this work, we have limited our study to the well-defined post-translational control of Myc. It is possible that robust control of Myc accumulation is facilitated by additional mechanisms, including Myc stabilization by a signal in the carboxy-terminus of Myc <xref ref-type="bibr" rid="pcbi.1000013-Tworkowski1">[45]</xref> and Myc sequestration for degradation <xref ref-type="bibr" rid="pcbi.1000013-Sanders1">[46]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Arabi1">[47]</xref>. Myc modulation is also tuned by regulations at other levels including post-transcription <xref ref-type="bibr" rid="pcbi.1000013-Endo1">[10]</xref> and translation <xref ref-type="bibr" rid="pcbi.1000013-Jopling1">[48]</xref>, along with feedback control <xref ref-type="bibr" rid="pcbi.1000013-Penn1">[9]</xref>. Furthermore, the activities of Pin1 and PP2A, which we assumed to be abundant and not rate-limiting, may further contribute to more complex Myc dynamics, as seen in various cancers <xref ref-type="bibr" rid="pcbi.1000013-Peunova1">[49]</xref>–<xref ref-type="bibr" rid="pcbi.1000013-Santos1">[52]</xref>.</p><p>As Myc is often deregulated in cancers, quantitative understanding of the mechanisms for Myc regulation may be helpful for developing novel strategies for cancer treatment. Myc stabilization processes consist of two temporally coordinated events: Myc stabilization by Erk and prevention of Myc degradation by PI3K. While the significance of Myc degradation by the second PI3K activity has been suggested in cell proliferation <xref ref-type="bibr" rid="pcbi.1000013-Kumar1">[16]</xref>, the extent to which the initial Myc stabilization by Erk contributes to cell proliferation remains unknown. Our model predicts that, for the second round of Myc accumulation, Myc needs to be sufficiently accumulated by Erk<sub>R</sub> prior to the second PI3K activity (black line in <xref ref-type="supplementary-material" rid="pcbi.1000013.s004">Figure S4</xref>). With the PI3K signal fixed, a small increase in Erk<sub>R</sub> is predicted to result in a significant increase in Myc accumulation pattern (red line in <xref ref-type="supplementary-material" rid="pcbi.1000013.s004">Figure S4</xref>). In contrast, removal of Erk<sub>R</sub> renders Myc unresponsive to the PI3K signal (blue line in <xref ref-type="supplementary-material" rid="pcbi.1000013.s004">Figure S4</xref>). This is due to the sequential nature of the Myc stabilization processes, where Erk activity must precede PI3K activity. In other words, while Erk ‘primes’ Myc activity, PI3K ‘fine-tunes’ Myc accumulation.</p><p>The priming ability of Erk for Myc modulation may play a critical role in distinct responses to different stimulations. Studies have shown that PC12 cells can be induced to undergo differentiation or proliferation in response to NGF or EGF <xref ref-type="bibr" rid="pcbi.1000013-Peunova1">[49]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Greene1">[50]</xref>, and the residual Erk level may be responsible for these differential cellular responses <xref ref-type="bibr" rid="pcbi.1000013-Sasagawa1">[21]</xref>. Our analysis suggests that the ability of Erk to modulate these cellular responses is through modulation of Myc accumulation. For EGF stimulation, the low residual Erk level may induce proliferation by weakly priming Myc (black line in <xref ref-type="supplementary-material" rid="pcbi.1000013.s004">Figure S4</xref>). In contrast, the high residual Erk level upon NGF stimulation may lead to a significant increase in Myc, inducing differentiation (red line in <xref ref-type="supplementary-material" rid="pcbi.1000013.s004">Figure S4</xref>). This notion can be experimentally tested by simultaneous time-course measurements of the input signals Erk and PI3K, and the output Myc protein. Also, the input signals can be independently controlled by inhibitor drugs <xref ref-type="bibr" rid="pcbi.1000013-Hennessy1">[51]</xref>, inducible systems, or siRNA molecules targeting the MAPK or PI3K pathways <xref ref-type="bibr" rid="pcbi.1000013-Santos1">[52]</xref>.</p><p>The assumed saturation of the input signals in the base model can also be experimentally tested. Our simulations indicate that the assumed saturation is a necessary condition for the overall robustness of Myc to parameters. This serves as an interesting question to explore experimentally. Also, as detailed in <xref ref-type="supplementary-material" rid="pcbi.1000013.s005">Figure S5</xref>, some constituent reactions in the PI3K pathway (e.g., the Ph-dePh cycles) have not been well-characterized at the quantitative level. Our additional model predictions on how the overall response of Gsk3β to PI3K depends on sensitivity characteristics of individual stages can serve as further targets for experimental tests.</p><p>The analysis of the Myc stabilization mechanism reveals a regulatory network motif that may be ubiquitously used in nature. Network motifs are small, recurring cellular regulatory networks, identified and characterized by their shared architectures and functions among diverse organisms. Well-known examples include feedback regulations, feed-forward loops, and their derivatives (see <xref ref-type="bibr" rid="pcbi.1000013-Lee1">[53]</xref>–<xref ref-type="bibr" rid="pcbi.1000013-Tyson1">[56]</xref> for review). Here we suggest that the dual-kinase motif represents another example with distinctive features.</p><p>The dual-kinase motif is similar to a well-studied phosphorylation-dephosphorylation enzymatic motif of protein modification. In both motifs, protein modification events occur sequentially, and the current state of the protein hinges upon its previous state. Given appropriate input signals and parameters, the sensitivity and amplitude of the output response can be precisely controlled <xref ref-type="bibr" rid="pcbi.1000013-Goldbeter1">[57]</xref>. The dual-kinase motif differs from the phosphorylation-dephosphorylation one, however, in that protein modification process is irreversible. Once phosphorylated, the stabilized protein cannot return to its initial state, but is targeted for degradation upon further modification. This distinctive characteristic contributes to additional features of the dual-kinase motif: sequential signal integration of multiple inputs and, correspondingly, flexible dynamic range for the output governed by protein stability modulation.</p></sec></sec><sec id="s3"><title>Model and Methods</title><sec id="s3a"><title>Myc Regulation by Erk and PI3K</title><p>Based on the reaction network outlined in <xref ref-type="fig" rid="pcbi-1000013-g001">Figure 1A</xref>, we developed a kinetic mathematical model in <italic>Dynetica</italic>, a graphics-based, integrated simulation platform <xref ref-type="bibr" rid="pcbi.1000013-You1">[58]</xref>. We further simplified the model by lumping the sequential destabilization processes together into the phosphorylation rate constant for Myc<sup>Thr58</sup> (<xref ref-type="supplementary-material" rid="pcbi.1000013.s001">Figure S1</xref>). This simplification was based on the observation that Pin1 and PP2A activation is not rate-limiting during cell cycle entry <xref ref-type="bibr" rid="pcbi.1000013-Shen1">[59]</xref>,<xref ref-type="bibr" rid="pcbi.1000013-Baharians1">[60]</xref>. Explicitly accounting for the sequential events by Pin1 and PP2A did not have significant impact on Myc accumulation. In addition, we assumed that the change in transactivation capacity due to stability control <xref ref-type="bibr" rid="pcbi.1000013-Yeh1">[14]</xref> is not significant, since Myc<sup>Ser62</sup> is much more predominant than Myc<sup>Thr58</sup>. Based on experimental data, we assumed phosphorylation of Myc at Ser62 or Thr58 to be much more significant than dephosphorylation. This results in sequential, irreversible Myc stabilization. However, we accounted specifically for the differential degradation dynamics of protein isoforms in this model.</p><p>To establish a framework that facilitates investigation of Myc modulation by its upstream signals, Erk and PI3K, we built the model with Erk and PI3K as the inputs and Myc as the output. Despite the extensive interactions between the MAPK and PI3K pathways, we decoupled Erk and PI3K signals and simplified them as a single or double rectangular pulses, respectively (<xref ref-type="fig" rid="pcbi-1000013-g001">Figure 1B</xref>). Such decoupling of these signals was driven by the objective of our study: to characterize Myc's response to various input signal patterns. Since activation of Erk and PI3K is specific to cell lines and stimulants (as shown in <xref ref-type="supplementary-material" rid="pcbi.1000013.s006">Table S1</xref> and <xref ref-type="supplementary-material" rid="pcbi.1000013.s007">S2</xref>), and is mediated by multiple signaling pathways including Ras, Rac, or Rap <xref ref-type="bibr" rid="pcbi.1000013-Chang1">[61]</xref>–<xref ref-type="bibr" rid="pcbi.1000013-Shen2">[64]</xref>, it is not clear to what extent these signaling pathways contribute to Erk and PI3K activation patterns. Furthermore, the Erk and PI3K pathways that control Myc protein turnover are a conserved motif found in both mammalian and yeast systems and such control motif has been speculated in many other protein stabilization processes <xref ref-type="bibr" rid="pcbi.1000013-EscamillaPowers1">[15]</xref>. In many of these processes, input signals are not triggered by a single protein. To set up a framework for a more general Myc stabilization process, we decoupled the two signals from each other and from their upstream network regulation and assumed their effects on Erk and PI3K in the decoupled inputs. This allowed analyzing Myc's response to variations in Erk and PI3K independently.</p><p>Based on experimental observations, we approximated input signals as rectangular pulses with three parameters: duration, the maximum level, and the residual level. To describe two-peak PI3K activation, we introduced another parameter, inter-peak delay. More sophisticated representations (for example, sinusoidal pulses) give similar results (data not shown). Although we focused on the two-peak activation of PI3K in the base model, the modeling framework can be extended to study other patterns of PI3K signals (such as a single peak pattern) by varying duration, steady-state values, or inter-peak delay (for example, see <xref ref-type="supplementary-material" rid="pcbi.1000013.s003">Figure S3</xref>).</p><p>As detailed in <xref ref-type="supplementary-material" rid="pcbi.1000013.s001">Figure S1</xref> and <xref ref-type="supplementary-material" rid="pcbi.1000013.s009">Tables S4</xref>, most reaction mechanisms and base model parameters were derived from experimental results in mouse or human cells. Others were carefully obtained or estimated from previous theoretical studies <xref ref-type="bibr" rid="pcbi.1000013-Hatakeyama1">[65]</xref>–<xref ref-type="bibr" rid="pcbi.1000013-Schoeberl1">[67]</xref>. To test the effect of uncertainty in these parameter values, we carried out parametric sensitivity analysis by increasing or decreasing each parameter by 10 fold of its base value while keeping the others constant (Figure S6). To quantify Myc's response to these changes, we used ‘potency’ or the shaded area under the Myc temporal profile curve (<xref ref-type="fig" rid="pcbi-1000013-g001">Figure 1B</xref>). This quantification method was previously used to characterize potency of transient activation of signaling protein <xref ref-type="bibr" rid="pcbi.1000013-Heinrich1">[68]</xref>. The parametric sensitivity analysis was performed in <italic>Matlab</italic>.</p></sec><sec id="s3b"><title>Modeling a Generic Dual Kinase Motif</title><p>Based on the connectivity in <xref ref-type="fig" rid="pcbi-1000013-g003">Figure 3A</xref>, we modeled the dual kinase motif using three highly simplified ordinary differential equations (ODEs), as presented in a dimensionless form:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.e002" xlink:type="simple"/></disp-formula>where <italic>x</italic>, <italic>x</italic><sub>P</sub>, and <italic>x<sub>PP</sub></italic> are the concentrations of the three forms of a molecule X; <italic>τ</italic> is an independent variable, time; <italic>κ</italic> describes the synthesis of X (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000013.e003" xlink:type="simple"/></inline-formula>); <italic>α</italic> is the activation efficiency by S<sub>1</sub> (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000013.e004" xlink:type="simple"/></inline-formula>); β is the deactivation efficiency by S<sub>2 </sub>(<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000013.e005" xlink:type="simple"/></inline-formula>); and <italic>η</italic> is the ratio of unstable protein to stable protein (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000013.e006" xlink:type="simple"/></inline-formula>), or <italic>stabilization efficiency</italic>. Without loss of generality and for simplification, we assumed that <italic>x</italic> and <italic>x<sub>pp</sub></italic> had the same stability.</p><p>Similar to Myc regulation, we used the total effector concentration X ( = <italic>x</italic>+<italic>x<sub>P</sub></italic>+<italic>x<sub>PP</sub></italic>) to represent the system output. As shown by a typical simulation (<xref ref-type="fig" rid="pcbi-1000013-g002">Figure 2B</xref>), this module enables integration of two signals by the effector module. Drawing analogy to electric signal processing, the output can be considered a combination of ‘NOT’ and ‘AND’ operators, which defines a pulse of output.</p></sec></sec><sec id="s4"><title>Supporting Information</title><supplementary-material id="pcbi.1000013.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s001" xlink:type="simple"><label>Figure S1</label><caption><p>Detailed reaction diagram for Myc protein stabilization.</p><p>(0.22 MB TIF)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s002" xlink:type="simple"><label>Figure S2</label><caption><p>Modeling a phosphorylation-dephosphorylation cycle. An enzymatic modification cycle of Gsk3β between phosphorylated and dephosphorylated states (A) is mathematically modeled (B). <italic>k</italic> and <italic>k<sub>GP</sub></italic> are rate constants for phosphorylation and dephosphorylation, and <italic>K</italic> is the Michaelis-Menten constant. Protein conversion is ultrasensitive near γ = 1, for a sufficiently small Michaelis-Menten constant. The sensitivity becomes weaker as <italic>K</italic> is increased. Time-course simulation results at varying values show the dependence of conversion on the rates of phosphorylation and dephosphorylation (C). Protein conversion becomes ultrasensitive near α = 1 for a sufficiently small Michaelis-Menten constant, while the sensitivity becomes weaker as <italic>K</italic> is increased.</p><p>(0.12 MB TIF)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s003" xlink:type="simple"><label>Figure S3</label><caption><p>Impact of varying PI3K inputs on Myc accumulation. (A) A single peak of Myc is predicted if the second round of PI3K activity is removed. This results in reduced Myc accumulation compared to the wild-type. (B) Increased inter-peak time delay of PI3K (from 3 to 8 hours) results in wider separation between the two peaks of Myc, and the resulting Myc accumulation is less than the wild-type.</p><p>(0.11 MB TIF)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s004" xlink:type="simple"><label>Figure S4</label><caption><p>Erk ‘primes’ Myc activity, and PI3K ‘fine-tunes’ Myc accumulation level. With the PI3K signal fixed, different residual Erk level leads to differential Myc accumulation by the second PI3K activity. The base value of the residual Erk level (ErkR) was 10 percent of maximal Erk level (black line). For increased level of ErkR (20%), the second PI3K activity increased Myc accumulation level significantly (red line). When ErkR was completely removed, Myc became unresponsive to the PI3K signal (blue line).</p><p>(0.09 MB TIF)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s005" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s005" xlink:type="simple"><label>Figure S5</label><caption><p>The overall ultrasensitivity arises from the input/output response in each level and across different levels down the cascade. (A) The Akt Ph-dePh cycle (in response to PI3K) can be either graded (red line) or ultrasensitive (blue line) depending on the Michaelis-Menten constants. (B) Both types of PI3K-Akt responses can lead to ultrasensitive PI3K-Gsk3β responses (both red and blue), if the Akt-Gsk3β response remains ultrasensitive. (C) If Akt-Gsk3β response is not ultrasensitive, the overall PI3K-Gsk3β remains ultrasensitive if PI3K-Akt response is ultrasensitive, but may lose ultrasensitivity if PI3K-Akt response is not ultrasensitive. Note that here we have assumed that the output from the first step (Akt<sub>P</sub>) has an appropriate dynamic range that “matches” the input of the second step. The dependence of the overall sensitivity of the PI3K-Gsk3β response will likely be much more complex if this matching condition is not satisfied.</p><p>(0.22 MB TIF)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s006" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s006" xlink:type="simple"><label>Table S1</label><caption><p>Erk signal pattern</p><p>(0.05 MB DOC)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s007" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s007" xlink:type="simple"><label>Table S2</label><caption><p>PI3K signal pattern</p><p>(0.05 MB DOC)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s008" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s008" xlink:type="simple"><label>Table S3</label><caption><p>Myc signal pattern</p><p>(0.03 MB DOC)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s009" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s009" xlink:type="simple"><label>Table S4</label><caption><p>Reaction kinetics</p><p>(0.09 MB DOC)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s010" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s010" xlink:type="simple"><label>Table S5</label><caption><p>Base model parameters and notes</p><p>(0.08 MB DOC)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s011" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s011" xlink:type="simple"><label>Table S6</label><caption><p>Parametric Sensitivity</p><p>(0.03 MB DOC)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s012" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s012" xlink:type="simple"><label>Table S7</label><caption><p>Parametric Sensitivity without ultrasensitivity</p><p>(0.03 MB DOC)</p></caption></supplementary-material><supplementary-material id="pcbi.1000013.s013" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000013.s013" xlink:type="simple"><label>Text S1</label><caption><p>(0.05 MB DOC)</p></caption></supplementary-material></sec></body><back><ack><p>We are grateful to the members of the You lab for helpful discussions.</p></ack><ref-list><title>References</title><ref id="pcbi.1000013-Pelengaris1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Pelengaris</surname><given-names>S</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M</given-names></name><name name-style="western"><surname>Evan</surname><given-names>G</given-names></name></person-group>             <year>2002</year>             <article-title>c-MYC: More than just a matter of life and death.</article-title>             <source>Nat Rev Cancer</source>             <volume>2</volume>             <fpage>764</fpage>             <lpage>776</lpage>          </element-citation></ref><ref id="pcbi.1000013-Adhikary1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Adhikary</surname><given-names>S</given-names></name><name name-style="western"><surname>Eilers</surname><given-names>M</given-names></name></person-group>             <year>2005</year>             <article-title>Transcriptional regulation and transformation by MYC proteins.</article-title>             <source>Nat Rev Mol Cell Biol</source>             <volume>6</volume>             <fpage>635</fpage>             <lpage>645</lpage>          </element-citation></ref><ref id="pcbi.1000013-Elend1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Elend</surname><given-names>M</given-names></name><name name-style="western"><surname>Eilers</surname><given-names>M</given-names></name></person-group>             <year>1999</year>             <article-title>Cell growth: downstream of Myc-to grow or to cycle?</article-title>             <source>Curr Biol</source>             <volume>9</volume>             <fpage>R936</fpage>             <lpage>R938</lpage>          </element-citation></ref><ref id="pcbi.1000013-Secombe1"><label>4</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Secombe</surname><given-names>J</given-names></name><name name-style="western"><surname>Pierce</surname><given-names>SB</given-names></name><name name-style="western"><surname>Eisenman</surname><given-names>RN</given-names></name></person-group>             <year>2004</year>             <article-title>Myc: a weapon of mass destruction.</article-title>             <source>Cell</source>             <volume>117</volume>             <fpage>153</fpage>             <lpage>156</lpage>          </element-citation></ref><ref id="pcbi.1000013-Bouchard1"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bouchard</surname><given-names>C</given-names></name><name name-style="western"><surname>Staller</surname><given-names>P</given-names></name><name name-style="western"><surname>Eilers</surname><given-names>M</given-names></name></person-group>             <year>1998</year>             <article-title>Control of cell proliferation by Myc.</article-title>             <source>Trends Cell Biol</source>             <volume>8</volume>             <fpage>202</fpage>             <lpage>206</lpage>          </element-citation></ref><ref id="pcbi.1000013-Evan1"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Evan</surname><given-names>GI</given-names></name><name name-style="western"><surname>Wyllie</surname><given-names>AH</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>CS</given-names></name><name name-style="western"><surname>Littlewood</surname><given-names>TD</given-names></name><name name-style="western"><surname>Land</surname><given-names>H</given-names></name><etal/></person-group>             <year>1992</year>             <article-title>Induction of Apoptosis in Fibroblasts by C-Myc Protein.</article-title>             <source>Cell</source>             <volume>69</volume>             <fpage>119</fpage>             <lpage>128</lpage>          </element-citation></ref><ref id="pcbi.1000013-Prendergast1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Prendergast</surname><given-names>GC</given-names></name></person-group>             <year>1999</year>             <article-title>Mechanisms of apoptosis by c-Myc.</article-title>             <source>Oncogene</source>             <volume>18</volume>             <fpage>2967</fpage>             <lpage>2987</lpage>          </element-citation></ref><ref id="pcbi.1000013-Schmidt1"><label>8</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>EV</given-names></name></person-group>             <year>1999</year>             <article-title>The role of c-myc in cellular growth control.</article-title>             <source>Oncogene</source>             <volume>18</volume>             <fpage>2988</fpage>             <lpage>2996</lpage>          </element-citation></ref><ref id="pcbi.1000013-Penn1"><label>9</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Penn</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Brooks</surname><given-names>MW</given-names></name><name name-style="western"><surname>Laufer</surname><given-names>EM</given-names></name><name name-style="western"><surname>Land</surname><given-names>H</given-names></name></person-group>             <year>1990</year>             <article-title>Negative autoregulation of c-myc transcription.</article-title>             <source>EMBO Jl</source>             <volume>9</volume>             <fpage>1113</fpage>             <lpage>1121</lpage>          </element-citation></ref><ref id="pcbi.1000013-Endo1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Endo</surname><given-names>T</given-names></name><name name-style="western"><surname>Nadal-Ginard</surname><given-names>B</given-names></name></person-group>             <year>1986</year>             <article-title>Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype.</article-title>             <source>Mol Cell Biol</source>             <volume>6</volume>             <fpage>1412</fpage>             <lpage>1421</lpage>          </element-citation></ref><ref id="pcbi.1000013-Levine1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Levine</surname><given-names>RA</given-names></name><name name-style="western"><surname>McCormack</surname><given-names>JE</given-names></name><name name-style="western"><surname>Buckler</surname><given-names>A</given-names></name><name name-style="western"><surname>Sonenshein</surname><given-names>GE</given-names></name></person-group>             <year>1986</year>             <article-title>Transcriptional and posttranscriptional control of c-myc gene expression in WEHI 231 cells.</article-title>             <source>Mol Cell Biol</source>             <volume>6</volume>             <fpage>4112</fpage>             <lpage>4116</lpage>          </element-citation></ref><ref id="pcbi.1000013-Sears1"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sears</surname><given-names>R</given-names></name><name name-style="western"><surname>Leone</surname><given-names>G</given-names></name><name name-style="western"><surname>DeGregori</surname><given-names>J</given-names></name><name name-style="western"><surname>Nevins</surname><given-names>JR</given-names></name></person-group>             <year>1999</year>             <article-title>Ras enhances Myc protein stability.</article-title>             <source>Mol Cell</source>             <volume>3</volume>             <fpage>169</fpage>             <lpage>179</lpage>          </element-citation></ref><ref id="pcbi.1000013-Sears2"><label>13</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sears</surname><given-names>R</given-names></name><name name-style="western"><surname>Nuckolls</surname><given-names>F</given-names></name><name name-style="western"><surname>Haura</surname><given-names>E</given-names></name><name name-style="western"><surname>Taya</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tamai</surname><given-names>K</given-names></name><etal/></person-group>             <year>2000</year>             <article-title>Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.</article-title>             <source>Genes Dev</source>             <volume>14</volume>             <fpage>2501</fpage>             <lpage>2514</lpage>          </element-citation></ref><ref id="pcbi.1000013-Yeh1"><label>14</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Yeh</surname><given-names>E</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>M</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>H</given-names></name><name name-style="western"><surname>Chasse</surname><given-names>D</given-names></name><name name-style="western"><surname>Monteith</surname><given-names>T</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.</article-title>             <source>Nat Cell Biol</source>             <volume>6</volume>             <fpage>308</fpage>             <lpage>318</lpage>          </element-citation></ref><ref id="pcbi.1000013-EscamillaPowers1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Escamilla-Powers</surname><given-names>JR</given-names></name><name name-style="western"><surname>Sears</surname><given-names>RC</given-names></name></person-group>             <year>2007</year>             <article-title>A conserved pathway that controls c-Myc protein stability through opposing phosphorylation events occurs in yeast.</article-title>             <source>J Biol Chem</source>             <volume>282</volume>             <fpage>5432</fpage>             <lpage>5442</lpage>          </element-citation></ref><ref id="pcbi.1000013-Kumar1"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name><name name-style="western"><surname>Marques</surname><given-names>M</given-names></name><name name-style="western"><surname>Carrera</surname><given-names>AC</given-names></name></person-group>             <year>2006</year>             <article-title>Phosphoinositide 3-Kinase Activation in Late G1 Is Required for c-Myc Stabilization and S Phase Entry.</article-title>             <source>Mol Cell Biol</source>             <volume>26</volume>             <fpage>9116</fpage>             <lpage>9125</lpage>          </element-citation></ref><ref id="pcbi.1000013-Sears3"><label>17</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sears</surname><given-names>RC</given-names></name><name name-style="western"><surname>Nevins</surname><given-names>JR</given-names></name></person-group>             <year>2002</year>             <article-title>Signaling networks that link cell proliferation and cell fate.</article-title>             <source>J Biol Chem</source>             <volume>277</volume>             <fpage>11617</fpage>             <lpage>11620</lpage>          </element-citation></ref><ref id="pcbi.1000013-Gregory1"><label>18</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gregory</surname><given-names>MA</given-names></name><name name-style="western"><surname>Hann</surname><given-names>SR</given-names></name></person-group>             <year>2000</year>             <article-title>c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.</article-title>             <source>Mol Cell Biol</source>             <volume>20</volume>             <fpage>2423</fpage>             <lpage>2435</lpage>          </element-citation></ref><ref id="pcbi.1000013-Vojtek1"><label>19</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Vojtek</surname><given-names>AB</given-names></name><name name-style="western"><surname>Der</surname><given-names>CJ</given-names></name></person-group>             <year>1998</year>             <article-title>Increasing complexity of the Ras signaling pathway.</article-title>             <source>J Biol Chem</source>             <volume>273</volume>             <fpage>19925</fpage>             <lpage>19928</lpage>          </element-citation></ref><ref id="pcbi.1000013-Ebisuya1"><label>20</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ebisuya</surname><given-names>M</given-names></name><name name-style="western"><surname>Kondoh</surname><given-names>K</given-names></name><name name-style="western"><surname>Nishida</surname><given-names>E</given-names></name></person-group>             <year>2005</year>             <article-title>The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity.</article-title>             <source>J Cell Science</source>             <volume>118</volume>             <fpage>2997</fpage>             <lpage>3002</lpage>          </element-citation></ref><ref id="pcbi.1000013-Sasagawa1"><label>21</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sasagawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Ozaki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fujita</surname><given-names>K</given-names></name><name name-style="western"><surname>Kuroda</surname><given-names>S</given-names></name></person-group>             <year>2005</year>             <article-title>Prediction and validation of the distinct dynamics of transient and sustained ERK activation.</article-title>             <source>Nat Cell Biol</source>             <volume>7</volume>             <fpage>U365</fpage>             <lpage>U331</lpage>          </element-citation></ref><ref id="pcbi.1000013-Traverse1"><label>22</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Traverse</surname><given-names>S</given-names></name><name name-style="western"><surname>Seedorf</surname><given-names>K</given-names></name><name name-style="western"><surname>Paterson</surname><given-names>H</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>P</given-names></name><etal/></person-group>             <year>1994</year>             <article-title>EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor.</article-title>             <source>Curr Biol</source>             <volume>4</volume>             <fpage>694</fpage>             <lpage>701</lpage>          </element-citation></ref><ref id="pcbi.1000013-Murphy1"><label>23</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>LO</given-names></name><name name-style="western"><surname>Smith</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>RH</given-names></name><name name-style="western"><surname>Fingar</surname><given-names>DC</given-names></name><name name-style="western"><surname>Blenis</surname><given-names>J</given-names></name></person-group>             <year>2002</year>             <article-title>Molecular interpretation of ERK signal duration by immediate early gene products. [see comment].</article-title>             <source>Nat Cell Biol</source>             <volume>4</volume>             <fpage>556</fpage>             <lpage>564</lpage>          </element-citation></ref><ref id="pcbi.1000013-Chaussepied1"><label>24</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chaussepied</surname><given-names>M</given-names></name><name name-style="western"><surname>Ginsberg</surname><given-names>D</given-names></name></person-group>             <year>2004</year>             <article-title>Transcriptional regulation of AKT activation by E2F.</article-title>             <source>Mol Cell</source>             <volume>16</volume>             <fpage>831</fpage>             <lpage>837</lpage>          </element-citation></ref><ref id="pcbi.1000013-Jones1"><label>25</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>SM</given-names></name><name name-style="western"><surname>Klinghoffer</surname><given-names>R</given-names></name><name name-style="western"><surname>Prestwich</surname><given-names>GD</given-names></name><name name-style="western"><surname>Toker</surname><given-names>A</given-names></name><name name-style="western"><surname>Kazlauskas</surname><given-names>A</given-names></name></person-group>             <year>1999</year>             <article-title>PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1.</article-title>             <source>Curr Biol</source>             <volume>9</volume>             <fpage>512</fpage>             <lpage>521</lpage>          </element-citation></ref><ref id="pcbi.1000013-Goncharova1"><label>26</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Goncharova</surname><given-names>EA</given-names></name><name name-style="western"><surname>Ammit</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Irani</surname><given-names>C</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>RG</given-names></name><name name-style="western"><surname>Eszterhas</surname><given-names>AJ</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells.</article-title>             <source>Am J Physiol Lung Cell Mol Physiol</source>             <volume>283</volume>             <fpage>L354</fpage>             <lpage>363</lpage>          </element-citation></ref><ref id="pcbi.1000013-Jones2"><label>27</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>SM</given-names></name><name name-style="western"><surname>Kazlauskas</surname><given-names>A</given-names></name></person-group>             <year>2001</year>             <article-title>Growth-factor-dependent mitogenesis requires two distinct phases of signalling.</article-title>             <source>Nat Cell Biol</source>             <volume>3</volume>             <fpage>165</fpage>             <lpage>172</lpage>          </element-citation></ref><ref id="pcbi.1000013-Garcia1"><label>28</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Garcia</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name><name name-style="western"><surname>Marques</surname><given-names>M</given-names></name><name name-style="western"><surname>Cortes</surname><given-names>I</given-names></name><name name-style="western"><surname>Carrera</surname><given-names>AC</given-names></name></person-group>             <year>2006</year>             <article-title>Phosphoinositide 3-kinase controls early and late events in mammalian cell division.</article-title>             <source>EMBO J</source>             <volume>25</volume>             <fpage>655</fpage>             <lpage>661</lpage>          </element-citation></ref><ref id="pcbi.1000013-ODonnell1"><label>29</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>O'Donnell</surname><given-names>KA</given-names></name><name name-style="western"><surname>Wentzel</surname><given-names>EA</given-names></name><name name-style="western"><surname>Zeller</surname><given-names>KI</given-names></name><name name-style="western"><surname>Dang</surname><given-names>CV</given-names></name><name name-style="western"><surname>Mendell</surname><given-names>JT</given-names></name></person-group>             <year>2005</year>             <article-title>c-Myc-regulated microRNAs modulate E2F1 expression.</article-title>             <source>Nature</source>             <volume>435</volume>             <fpage>839</fpage>             <lpage>843</lpage>          </element-citation></ref><ref id="pcbi.1000013-Park1"><label>30</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>CS</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>IC</given-names></name><name name-style="western"><surname>Haugh</surname><given-names>JM</given-names></name></person-group>             <year>2003</year>             <article-title>Kinetic Analysis of Platelet-derived Growth Factor Receptor/Phosphoinositide 3-Kinase/Akt Signaling in Fibroblasts.</article-title>             <source>J Biol Chem</source>             <volume>278</volume>             <fpage>37064</fpage>             <lpage>37072</lpage>          </element-citation></ref><ref id="pcbi.1000013-Kaur1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kaur</surname><given-names>H</given-names></name><name name-style="western"><surname>Park</surname><given-names>CS</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>JM</given-names></name><name name-style="western"><surname>Haugh</surname><given-names>JM</given-names></name></person-group>             <year>2006</year>             <article-title>Quantitative model of Ras phosphoinositide 3-kinase signalling cross-talk based on co-operative molecular assembly.</article-title>             <source>Biochem J</source>             <volume>393</volume>             <fpage>235</fpage>             <lpage>243</lpage>          </element-citation></ref><ref id="pcbi.1000013-Novak1"><label>32</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Novak</surname><given-names>B</given-names></name><name name-style="western"><surname>Tyson</surname><given-names>JJ</given-names></name></person-group>             <year>2004</year>             <article-title>A model for restriction point control of the mammalian cell cycle.</article-title>             <source>J Theor Biol</source>             <volume>230</volume>             <fpage>563</fpage>             <lpage>579</lpage>          </element-citation></ref><ref id="pcbi.1000013-Aguda1"><label>33</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Aguda</surname><given-names>BD</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name></person-group>             <year>1999</year>             <article-title>The kinetic origins of the restriction point in the mammalian cell cycle.</article-title>             <source>Cell Proliferation</source>             <volume>32</volume>             <fpage>321</fpage>             <lpage>335</lpage>          </element-citation></ref><ref id="pcbi.1000013-Qu1"><label>34</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Qu</surname><given-names>Z</given-names></name><name name-style="western"><surname>MacLellan</surname><given-names>WR</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>JN</given-names></name></person-group>             <year>2003</year>             <article-title>Dynamics of the cell cycle: checkpoints, sizers, and timers.</article-title>             <source>Biophys J</source>             <volume>85</volume>             <fpage>3600</fpage>             <lpage>3611</lpage>          </element-citation></ref><ref id="pcbi.1000013-Wang1"><label>35</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>B</given-names></name><name name-style="western"><surname>Xia</surname><given-names>X</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Z</given-names></name></person-group>             <year>2006</year>             <article-title>Funneled Landscape Leads to Robustness of Cellular Networks: MAPK Signal Transduction.</article-title>             <source>Biophys J: biophysj.106.086777.</source>          </element-citation></ref><ref id="pcbi.1000013-Segrelles1"><label>36</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Segrelles</surname><given-names>C</given-names></name><name name-style="western"><surname>Moral</surname><given-names>M</given-names></name><name name-style="western"><surname>Lara</surname><given-names>MF</given-names></name><name name-style="western"><surname>Ruiz</surname><given-names>S</given-names></name><name name-style="western"><surname>Santos</surname><given-names>M</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Molecular determinants of Akt-induced keratinocyte transformation.</article-title>             <source>Oncogene</source>             <volume>25</volume>             <fpage>1174</fpage>             <lpage>1185</lpage>          </element-citation></ref><ref id="pcbi.1000013-Nilsson1"><label>37</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Nilsson</surname><given-names>JA</given-names></name><name name-style="western"><surname>Cleveland</surname><given-names>JL</given-names></name></person-group>             <year>2003</year>             <article-title>Myc pathways provoking cell suicide and cancer.</article-title>             <source>Oncogene</source>             <volume>22</volume>             <fpage>9007</fpage>             <lpage>9021</lpage>          </element-citation></ref><ref id="pcbi.1000013-Assoian1"><label>38</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Assoian</surname><given-names>RK</given-names></name></person-group>             <year>2002</year>             <article-title>Common sense signalling.</article-title>             <source>Nat Cell Biol</source>             <volume>4</volume>             <fpage>E187</fpage>             <lpage>188</lpage>          </element-citation></ref><ref id="pcbi.1000013-Musti1"><label>39</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Musti</surname><given-names>AM</given-names></name><name name-style="western"><surname>Treier</surname><given-names>M</given-names></name><name name-style="western"><surname>Bohmann</surname><given-names>D</given-names></name></person-group>             <year>1997</year>             <article-title>Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases.</article-title>             <source>Science</source>             <volume>275</volume>             <fpage>400</fpage>             <lpage>402</lpage>          </element-citation></ref><ref id="pcbi.1000013-Zeng1"><label>40</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>X</given-names></name><name name-style="western"><surname>Tamai</surname><given-names>K</given-names></name><name name-style="western"><surname>Doble</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>ST</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation.</article-title>             <source>Nature</source>             <volume>438</volume>             <fpage>873</fpage>             <lpage>877</lpage>          </element-citation></ref><ref id="pcbi.1000013-Mailand1"><label>41</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mailand</surname><given-names>N</given-names></name><name name-style="western"><surname>Podtelejnikov</surname><given-names>AV</given-names></name><name name-style="western"><surname>Groth</surname><given-names>A</given-names></name><name name-style="western"><surname>Mann</surname><given-names>M</given-names></name><name name-style="western"><surname>Bartek</surname><given-names>J</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability.</article-title>             <source>EMBO J</source>             <volume>21</volume>             <fpage>5911</fpage>             <lpage>5920</lpage>          </element-citation></ref><ref id="pcbi.1000013-Amit1"><label>42</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Amit</surname><given-names>S</given-names></name><name name-style="western"><surname>Hatzubai</surname><given-names>A</given-names></name><name name-style="western"><surname>Birman</surname><given-names>Y</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>JS</given-names></name><name name-style="western"><surname>Ben-Shushan</surname><given-names>E</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.</article-title>             <source>Genes Dev</source>             <volume>16</volume>             <fpage>1066</fpage>             <lpage>1076</lpage>          </element-citation></ref><ref id="pcbi.1000013-Hergovich1"><label>43</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hergovich</surname><given-names>A</given-names></name><name name-style="western"><surname>Lisztwan</surname><given-names>J</given-names></name><name name-style="western"><surname>Thoma</surname><given-names>CR</given-names></name><name name-style="western"><surname>Wirbelauer</surname><given-names>C</given-names></name><name name-style="western"><surname>Barry</surname><given-names>RE</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3.</article-title>             <source>Mol Cell Biol</source>             <volume>26</volume>             <fpage>5784</fpage>             <lpage>5796</lpage>          </element-citation></ref><ref id="pcbi.1000013-Liu1"><label>44</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>CM</given-names></name><name name-style="western"><surname>Li</surname><given-names>YM</given-names></name><name name-style="western"><surname>Semenov</surname><given-names>M</given-names></name><name name-style="western"><surname>Han</surname><given-names>C</given-names></name><name name-style="western"><surname>Baeg</surname><given-names>GH</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.</article-title>             <source>Cell</source>             <volume>108</volume>             <fpage>837</fpage>             <lpage>847</lpage>          </element-citation></ref><ref id="pcbi.1000013-Tworkowski1"><label>45</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tworkowski</surname><given-names>KA</given-names></name><name name-style="western"><surname>Salghetti</surname><given-names>SE</given-names></name><name name-style="western"><surname>Tansey</surname><given-names>WP</given-names></name></person-group>             <year>2002</year>             <article-title>Stable and unstable pools of Myc protein exist in human cells.</article-title>             <source>Oncogene</source>             <volume>21</volume>             <fpage>8515</fpage>             <lpage>8520</lpage>          </element-citation></ref><ref id="pcbi.1000013-Sanders1"><label>46</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sanders</surname><given-names>JA</given-names></name><name name-style="western"><surname>Gruppuso</surname><given-names>PA</given-names></name></person-group>             <year>2005</year>             <article-title>Nucleolar localization of hepatic c-Myc: a potential mechanism for c-Myc regulation.</article-title>             <source>Biochim Biophys Acta</source>             <volume>1743</volume>             <fpage>141</fpage>             <lpage>150</lpage>          </element-citation></ref><ref id="pcbi.1000013-Arabi1"><label>47</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Arabi</surname><given-names>A</given-names></name><name name-style="western"><surname>Rustum</surname><given-names>C</given-names></name><name name-style="western"><surname>Hallberg</surname><given-names>E</given-names></name><name name-style="western"><surname>Wright</surname><given-names>APH</given-names></name></person-group>             <year>2003</year>             <article-title>Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels.</article-title>             <source>J Cell Sci</source>             <volume>116</volume>             <fpage>1707</fpage>             <lpage>1717</lpage>          </element-citation></ref><ref id="pcbi.1000013-Jopling1"><label>48</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jopling</surname><given-names>CL</given-names></name><name name-style="western"><surname>Willis</surname><given-names>AE</given-names></name></person-group>             <year>2001</year>             <article-title>N-myc translation is initiated via an internal ribosome entry segment that displays enhanced activity in neuronal cells.</article-title>             <source>Oncogene</source>             <volume>20</volume>             <fpage>2664</fpage>             <lpage>2670</lpage>          </element-citation></ref><ref id="pcbi.1000013-Peunova1"><label>49</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Peunova</surname><given-names>N</given-names></name><name name-style="western"><surname>Enikolopov</surname><given-names>G</given-names></name></person-group>             <year>1995</year>             <article-title>Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells.</article-title>             <source>Nature</source>             <volume>375</volume>             <fpage>68</fpage>             <lpage>73</lpage>          </element-citation></ref><ref id="pcbi.1000013-Greene1"><label>50</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Greene</surname><given-names>LA</given-names></name><name name-style="western"><surname>Tischler</surname><given-names>AS</given-names></name></person-group>             <year>1976</year>             <article-title>Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>73</volume>             <fpage>2424</fpage>             <lpage>2428</lpage>          </element-citation></ref><ref id="pcbi.1000013-Hennessy1"><label>51</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hennessy</surname><given-names>BT</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name><name name-style="western"><surname>Ram</surname><given-names>PT</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mills</surname><given-names>GB</given-names></name></person-group>             <year>2005</year>             <article-title>Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery.</article-title>             <source>Nat Rev Drug Discov</source>             <volume>4</volume>             <fpage>988</fpage>             <lpage>1004</lpage>          </element-citation></ref><ref id="pcbi.1000013-Santos1"><label>52</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Santos</surname><given-names>SDM</given-names></name><name name-style="western"><surname>Verveer</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Bastiaens</surname><given-names>PIH</given-names></name></person-group>             <year>2007</year>             <article-title>Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate.</article-title>             <source>Nat Cell Biol</source>             <volume>9</volume>             <fpage>324</fpage>             <lpage>330</lpage>          </element-citation></ref><ref id="pcbi.1000013-Lee1"><label>53</label><element-citation publication-type="book" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>T</given-names></name><name name-style="western"><surname>Tan</surname><given-names>C</given-names></name><name name-style="western"><surname>Tu</surname><given-names>D</given-names></name><name name-style="western"><surname>You</surname><given-names>L</given-names></name></person-group>             <year>2007</year>             <article-title>Modeling Cellular Networks.</article-title>             <person-group person-group-type="editor"><name name-style="western"><surname>Alterovitz</surname><given-names>G</given-names></name><name name-style="western"><surname>Ramoni</surname><given-names>M</given-names></name></person-group>             <source>Bioinformatics: An Engineering Case-Based Approach. 1st edition</source>             <publisher-name>Artech House Publishers</publisher-name>          </element-citation></ref><ref id="pcbi.1000013-Alon1"><label>54</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Alon</surname><given-names>U</given-names></name></person-group>             <year>2007</year>             <article-title>Network motifs: theory and experimental approaches.</article-title>             <source>Nat Rev Genet</source>             <volume>8</volume>             <fpage>450</fpage>             <lpage>461</lpage>          </element-citation></ref><ref id="pcbi.1000013-Wolf1"><label>55</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wolf</surname><given-names>DM</given-names></name><name name-style="western"><surname>Arkin</surname><given-names>AP</given-names></name></person-group>             <year>2003</year>             <article-title>Motifs, modules and games in bacteria.</article-title>             <source>Curr Opin Microbiol</source>             <volume>6</volume>             <fpage>125</fpage>             <lpage>134</lpage>          </element-citation></ref><ref id="pcbi.1000013-Tyson1"><label>56</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tyson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>KC</given-names></name><name name-style="western"><surname>Novak</surname><given-names>B</given-names></name></person-group>             <year>2003</year>             <article-title>Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell.</article-title>             <source>Curr Opin Cell Biol</source>             <volume>15</volume>             <fpage>221</fpage>             <lpage>231</lpage>          </element-citation></ref><ref id="pcbi.1000013-Goldbeter1"><label>57</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Goldbeter</surname><given-names>A</given-names></name><name name-style="western"><surname>Koshland</surname><given-names>DE</given-names><suffix>Jr</suffix></name></person-group>             <year>1987</year>             <article-title>Energy expenditure in the control of biochemical systems by covalent modification.</article-title>             <source>J Biol Chem</source>             <volume>262</volume>             <fpage>4460</fpage>             <lpage>4471</lpage>          </element-citation></ref><ref id="pcbi.1000013-You1"><label>58</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>You</surname><given-names>LC</given-names></name><name name-style="western"><surname>Hoonlor</surname><given-names>A</given-names></name><name name-style="western"><surname>Yin</surname><given-names>J</given-names></name></person-group>             <year>2003</year>             <article-title>Modeling biological systems using Dynetica–a simulator of dynamic networks.</article-title>             <source>Bioinformatics</source>             <volume>19</volume>             <fpage>435</fpage>             <lpage>436</lpage>          </element-citation></ref><ref id="pcbi.1000013-Shen1"><label>59</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>M</given-names></name><name name-style="western"><surname>Stukenberg</surname><given-names>PT</given-names></name><name name-style="western"><surname>Kirschner</surname><given-names>MW</given-names></name><name name-style="western"><surname>Lu</surname><given-names>KP</given-names></name></person-group>             <year>1998</year>             <article-title>The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins.</article-title>             <source>Genes &amp; Development</source>             <volume>12</volume>             <fpage>706</fpage>             <lpage>720</lpage>          </element-citation></ref><ref id="pcbi.1000013-Baharians1"><label>60</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Baharians</surname><given-names>Z</given-names></name><name name-style="western"><surname>Schonthal</surname><given-names>AH</given-names></name></person-group>             <year>1998</year>             <article-title>Autoregulation of protein phosphatase type 2A expression.</article-title>             <source>J Biol Chem</source>             <volume>273</volume>             <fpage>19019</fpage>             <lpage>19024</lpage>          </element-citation></ref><ref id="pcbi.1000013-Chang1"><label>61</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>F</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JT</given-names></name><name name-style="western"><surname>Navolanic</surname><given-names>PM</given-names></name><name name-style="western"><surname>Steelman</surname><given-names>LS</given-names></name><name name-style="western"><surname>Shelton</surname><given-names>JG</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.</article-title>             <source>Leukemia</source>             <volume>17</volume>             <fpage>590</fpage>             <lpage>603</lpage>          </element-citation></ref><ref id="pcbi.1000013-Luo1"><label>62</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>J</given-names></name><name name-style="western"><surname>Manning</surname><given-names>BD</given-names></name><name name-style="western"><surname>Cantley</surname><given-names>LC</given-names></name></person-group>             <year>2003</year>             <article-title>Targeting the PI3K-Akt pathway in human cancer: Rationale and promise.</article-title>             <source>Cancer Cell</source>             <volume>4</volume>             <fpage>257</fpage>             <lpage>262</lpage>          </element-citation></ref><ref id="pcbi.1000013-Stork1"><label>63</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Stork</surname><given-names>PJS</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>JM</given-names></name></person-group>             <year>2002</year>             <article-title>Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation.</article-title>             <source>Trends Cell Biol</source>             <volume>12</volume>             <fpage>258</fpage>             <lpage>266</lpage>          </element-citation></ref><ref id="pcbi.1000013-Shen2"><label>64</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>YH</given-names></name><name name-style="western"><surname>Godlewski</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><name name-style="western"><surname>Sathyanarayana</surname><given-names>P</given-names></name><name name-style="western"><surname>Leaner</surname><given-names>V</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Cross talk between JNK/SAPK and ERK/MAPK pathways: Sustained activation of JNK blocks ERK activation by mitogenic factors.</article-title>             <source>J Biol Chem: M303264200</source>          </element-citation></ref><ref id="pcbi.1000013-Hatakeyama1"><label>65</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hatakeyama</surname><given-names>M</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>S</given-names></name><name name-style="western"><surname>Naka</surname><given-names>T</given-names></name><name name-style="western"><surname>Kawasaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Yumoto</surname><given-names>N</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling.</article-title>             <source>Biochem J</source>             <volume>373</volume>             <fpage>451</fpage>             <lpage>463</lpage>          </element-citation></ref><ref id="pcbi.1000013-Kholodenko1"><label>66</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kholodenko</surname><given-names>BN</given-names></name></person-group>             <year>2006</year>             <article-title>Cell-signalling dynamics in time and space.</article-title>             <source>Nat Rev Mol Cell Biol</source>             <volume>7</volume>             <fpage>165</fpage>             <lpage>176</lpage>          </element-citation></ref><ref id="pcbi.1000013-Schoeberl1"><label>67</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Schoeberl</surname><given-names>B</given-names></name><name name-style="western"><surname>Eichler-Jonsson</surname><given-names>C</given-names></name><name name-style="western"><surname>Gilles</surname><given-names>ED</given-names></name><name name-style="western"><surname>Muller</surname><given-names>G</given-names></name></person-group>             <year>2002</year>             <article-title>Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. [see comment].</article-title>             <source>Nat Biotechnol</source>             <volume>20</volume>             <fpage>370</fpage>             <lpage>375</lpage>          </element-citation></ref><ref id="pcbi.1000013-Heinrich1"><label>68</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Heinrich</surname><given-names>R</given-names></name><name name-style="western"><surname>Neel</surname><given-names>BG</given-names></name><name name-style="western"><surname>Rapoport</surname><given-names>TA</given-names></name></person-group>             <year>2002</year>             <article-title>Mathematical models of protein kinase signal transduction.</article-title>             <source>Mol Cell</source>             <volume>9</volume>             <fpage>957</fpage>             <lpage>970</lpage>          </element-citation></ref></ref-list></back></article>